Ahmed Daak
Corporate Officer/Principal chez International Society for the Study of Fatty Acids & Lipids
Profil
Ahmed Daak currently works at International Society for the Study of Fatty Acids & Lipids, as Member.
Dr. Daak also formerly worked at the University of Khartoum, as Assistant Professor and Sancilio Pharmaceuticals Co., Inc., as VP-Medical Research & Clinical Development.
Dr. Daak received his undergraduate degree, graduate degree, and doctorate degree from the University of London.
Postes actifs de Ahmed Daak
| Sociétés | Poste | Début |
|---|---|---|
| International Society for the Study of Fatty Acids & Lipids | Corporate Officer/Principal | - |
Anciens postes connus de Ahmed Daak
| Sociétés | Poste | Fin |
|---|---|---|
| University of Khartoum | Corporate Officer/Principal | - |
Sancilio Pharmaceuticals Co., Inc.
 Sancilio Pharmaceuticals Co., Inc. Miscellaneous Commercial ServicesCommercial Services Sancilio Pharmaceuticals Co. engaged in the development and manufacture of pharmaceutical products. Its product platform, advanced lipid technologies, focuses on the treatment of diseases and disorders related to lipids such as sickle cell, short bowel, severe hypertriglyceridemia and non-alcoholic fatty liver. The company was founded by Frederick Sancilio in October 2004 and was headquartered in Riviera Beach, FL. | Directeur Technique/Scientifique/R&D | - |
Formation de Ahmed Daak
| University of London | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Sancilio Pharmaceuticals Co., Inc.
Sancilio Pharmaceuticals Co., Inc. Miscellaneous Commercial ServicesCommercial Services Sancilio Pharmaceuticals Co. engaged in the development and manufacture of pharmaceutical products. Its product platform, advanced lipid technologies, focuses on the treatment of diseases and disorders related to lipids such as sickle cell, short bowel, severe hypertriglyceridemia and non-alcoholic fatty liver. The company was founded by Frederick Sancilio in October 2004 and was headquartered in Riviera Beach, FL. | Commercial Services |
| International Society for the Study of Fatty Acids & Lipids |
